NEW YORK–(BUSINESS WIRE)–BTIG announced today that it will hold an inaugural China Biotech Day, on Wednesday, June 1, 2022. This virtual event will include thematic panel discussions, fireside chats and one-on-one meetings. The conference will be hosted by:
Industry-leading biotechnology companies with operations in China will be participating in the firm�s conference. Management teams from each company will have an opportunity to directly connect with BTIGs institutional investor clients. The Chinese biotech sector is primed for growth due to accelerating drug development entering the global marketplace, said Justin Zelin, BTIG Biotechnology Analyst. Our event will provide a forum for BTIGs institutional investor clients to explore emerging innovations, discuss latest trends, and see whats on the horizon.
More than 13 public and private biotechnology companies will be participating in the event. Panel discussion topics will include state of China biotech investments, cross border collaborations, Chinas healthcare market and reimbursement, and accounting standards.
Mr. Zelins coverage specializes in cell therapy, targeted oncology, immunology and auto-immune disease therapeutics. Mr. Hazlett covers several therapeutic categories in the biotechnology sector, with a focus on CNS, oncology, rare disease and anti-infective companies. Their research with Mr. Boltanskys policy analysis provide investors and companies a comprehensive perspective on biotechnologys expanding economic impacts worldwide.
For more information about the conference, email info@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.
The conference is being produced by BTIGs Corporate Access program which hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate and technology sectors.
About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 725 employees, BTIG, LLC and its affiliates operate out of 22 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firms core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.
Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.
Contacts
Media:
Jill Gordon
443.668.2055
jgordon@prosek.com
Ariana Crupi
212.738.6142
acrupi@btig.com
SINGAPORE - Media OutReach Newswire - 29 April 2024 - From 26 April to 12…
SINGAPORE - Media OutReach Newswire - 29 April 2024 - XT, the world's first socially…
LONDON--(BUSINESS WIRE)--#BonteFriedheim--NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector,…
H2SITE’s AMMONIA to H2POWER technology for ammonia cracking on-board has received Approval in Principle (AiP)…
Daiichi Sankyo and AstraZeneca’s ENHERTU also demonstrated a clinically meaningful progression-free survival improvement in patients…
Q1 2024 Group sales at $7.4 billion, -20% (-18% at CER) versus prior year Q1…